NS102
Appearance
Names | |
---|---|
IUPAC name
5-Nitro-6,7,8,9-tetrahydro-1H-benzo[g]indole-2,3-dione 3-oxime
| |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
PubChemCID
|
|
UNII | |
CompTox Dashboard(EPA)
|
|
| |
| |
Properties | |
C12H11N3O4 | |
Molar mass | 261.237g·mol−1 |
Appearance | Yellow solid |
Insoluble | |
Solubilityin DMSO | >3 mg/mL |
Except where otherwise noted, data are given for materials in theirstandard state(at 25 °C [77 °F], 100 kPa).
|
NS102is akainate receptorantagonist.[2][3]
References
[edit]- ^NS102atSigma-Aldrich
- ^Johansen, Tina H; Drejer, Joergen; Watjen, Frank; Nielsen, Elsebet O (1993). "A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding".European Journal of Pharmacology.246(3): 195–204.doi:10.1016/0922-4106(93)90031-4.PMID8223944.
- ^Dev KK, Petersen V, Honoré T, Henley JM (1996). "Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain".J. Neurochem.67(6): 2609–12.doi:10.1046/j.1471-4159.1996.67062609.x.PMID8931496.S2CID39382212.